Alana Goldstein-Leever1,2, Lindsey L Cohen3,4, Carlton Dampier4,5, Soumitri Sil4,5. 1. Division of Pediatric Psychology and Neuropsychology, Nationwide Children's Hospital, Columbus, Ohio. 2. Department of Pediatrics, The Ohio State University, Columbus, Ohio. 3. Department of Psychology, Georgia State University, Atlanta, Georgia. 4. Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia. 5. Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
Abstract
BACKGROUND: Youth with sickle cell disease (SCD) are at risk for recurrent pain and depressive symptoms, both of which contribute to poorer health outcomes. Furthermore, youth and family coping with child pain, including pain catastrophizing, is known to be associated with poorer psychosocial adjustment and greater functional disability among youth with SCD. In particular, child catastrophizing about pain and parent catastrophizing about their child's pain have been linked to increased pain and depressive symptoms in youth with chronic pain conditions. Despite this, the impact of child and parent pain catastrophizing on depressive symptoms remains unexplored in pediatric SCD. PROCEDURE: The current study evaluated the predictive value of child and parent pain catastrophizing on child depressive symptoms in a sample of 100 youth with SCD. Differences in child and parent pain catastrophizing across youth with and without clinically elevated depressive symptoms were also examined. RESULTS: Pain frequency and parent and child pain catastrophizing accounted for 35.9% of variance in child depressive symptoms, with only pain frequency and parent pain catastrophizing emerging as unique predictors of clinically elevated depressive symptoms. Additionally, parents of youth with clinically elevated depressive symptoms showed increased helplessness relative to parents of youth with minimal to mild depressive symptoms. CONCLUSIONS: Findings support the value of depression screening and interventions to promote parent self-efficacy in managing childhood SCD pain.
BACKGROUND: Youth with sickle cell disease (SCD) are at risk for recurrent pain and depressive symptoms, both of which contribute to poorer health outcomes. Furthermore, youth and family coping with childpain, including pain catastrophizing, is known to be associated with poorer psychosocial adjustment and greater functional disability among youth with SCD. In particular, child catastrophizing about pain and parent catastrophizing about their child's pain have been linked to increased pain and depressive symptoms in youth with chronic pain conditions. Despite this, the impact of child and parent pain catastrophizing on depressive symptoms remains unexplored in pediatric SCD. PROCEDURE: The current study evaluated the predictive value of child and parent pain catastrophizing on childdepressive symptoms in a sample of 100 youth with SCD. Differences in child and parent pain catastrophizing across youth with and without clinically elevated depressive symptoms were also examined. RESULTS:Pain frequency and parent and childpain catastrophizing accounted for 35.9% of variance in childdepressive symptoms, with only pain frequency and parent pain catastrophizing emerging as unique predictors of clinically elevated depressive symptoms. Additionally, parents of youth with clinically elevated depressive symptoms showed increased helplessness relative to parents of youth with minimal to mild depressive symptoms. CONCLUSIONS: Findings support the value of depression screening and interventions to promote parent self-efficacy in managing childhood SCD pain.
Authors: Susan T Tran; Kristen E Jastrowski Mano; Keri R Hainsworth; Gustavo R Medrano; Kimberly Anderson Khan; Steven J Weisman; W Hobart Davies Journal: J Pediatr Psychol Date: 2015-04-02
Authors: Steven K Reader; Laura M Rockman; Katherine M Okonak; Nicole M Ruppe; Colleen N Keeler; Anne E Kazak Journal: J Clin Psychol Med Settings Date: 2020-06
Authors: Megan M Miller; Deanna D Rumble; Adam T Hirsh; Tine Vervoort; Lori E Crosby; Avi Madan-Swain; Jeffrey Lebensburger; Anna M Hood; Zina Trost Journal: Pain Med Date: 2021-10-08 Impact factor: 3.750